Hospitals unable to accurately forecast and manage drug rebate liabilities under changing 340B program regulations

Hospital finance teams face unpredictable rebate obligations that directly impact their already-constrained budgets, with regulatory changes creating sudden financial exposure. Current accounting and forecasting systems cannot adapt quickly enough to policy shifts, leaving hospitals unable to accurately model cash flow or budget for compliance costs. This creates operational chaos as hospitals must repeatedly restructure their drug procurement strategies and financial planning.